Influence of P-Glycoprotein Inhibition or Deficiency at the Blood–Brain Barrier on 18F-2-Fluoro-2-Deoxy-d -glucose (18F-FDG) Brain Kinetics
Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 3
Abstract
The fluorinated d -glucose analog 18F-2-fluoro-2-deoxy-d -glucose (18F-FDG) is the most prevalent radiopharmaceutical for positron emission tomography (PET) imaging. P-Glycoprotein’s (P-gp, MDR1, and ABCB1) function in various cancer cell lines and tumors was shown to impact 18F-FDG incorporation, suggesting that P-gp function at the blood–brain barrier may also modulate 18F-FDG brain kinetics. We tested the influence of P-gp inhibition using the cyclosporine analog valspodar (PSC833; 5 μM) on the uptake of 18F-FDG in standardized human P-gp-overexpressing cells (MDCKII-MDR1). Consequences for 18F-FDG brain kinetics were then assessed using (i) 18F-FDG PET imaging and suitable kinetic modelling in baboons without or with P-gp inhibition by intravenous cyclosporine infusion (15 mg kg−1 h−1) and (ii) in situ brain perfusion in wild-type and P-gp/Bcrp (breast cancer resistance protein) knockout mice and controlled d -glucose exposure to the brain. In vitro, the time course of 18F-FDG uptake in MDR1 cells was influenced by the presence of valspodar in the absence of d -glucose but not in the presence of high d -glucose concentration. PET analysis revealed that P-gp inhibition had no significant impact on estimated brain kinetics parameters K1, k2, k3, VT, and CMRGlc. The lack of P-gp effect on in vivo18F-FDG brain distribution was confirmed in P-gp/Bcrp-deficient mice. P-gp inhibition indirectly modulates 18F-FDG uptake into P-gp-overexpressing cells, possibly through differences in the energetic cell level state. 18F-FDG is not a P-gp substrate at the BBB and 18F-FDG brain kinetics as well as estimated brain glucose metabolism are influenced by neither P-gp inhibition nor P-gp/Bcrp deficiencies in baboon and mice, respectively.
Authors and Affiliations
Nicolas Tournier, Wadad Saba, Sébastien Goutal, Philippe Gervais, Héric Valette, Jean-Michel Scherrmann, Michel Bottlaender, Salvatore Cisternino
Keywords
Related Articles
- EP ID EP680951
- DOI 10.1208/s12248-015-9739-3
- Views 59
- Downloads 0
TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database
Target identification of the known bioactive compounds and novel synthetic analogs is a very important research field in medicinal chemistry, biochemistry, and pharmacology. It is also a challenging and costly step towar...
Physical chemical stability of warfarin sodium
Crystalline warfarin sodium is an isopropanol clathrate containing 8.3% isopropyl alcohol (IPA) and 0.57% water upon receipt. The hygroscopicity and impact of moisture on IPA status as well as on the stability of the cla...
Impact of Epigenetic Dietary Compounds on Transgenerational Prevention of Human Diseases
The etiology of most human diseases involves complicated interactions of multiple environmental factors with individual genetic background which is initially generated early in human life, for example, during the process...
Prevention of Collagen-Induced Platelet Binding and Activation by Thermosensitive Nanoparticles
Peripheral artery disease is an atherosclerotic occlusion in the peripheral vasculature that is typically treated via percutaneous transluminal angioplasty. Unfortunately, deployment of the angioplasty balloon damages th...
Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution
Quantification of target site pharmacokinetics (PK) is crucial for drug discovery and development. Clinical micro-dialysis (MD) has increasingly been employed for the description of drug distribution and receptor phase P...